461.54
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt UTHR?
Forum
Prognose
Aktiensplit
United Therapeutics Corp Aktie (UTHR) Neueste Nachrichten
Heatmap analysis for United Therapeutics Corporation and competitors2025 Growth vs Value & Consistent Income Trade Recommendations - newser.com
Chmn Rothblatt Files To Sell 4,000 Of United Therapeutics Corp [UTHR] - TradingView
United Therapeutics (UTHR): Stock Up 44.4%, Strong Growth & Cash FlowNews and Statistics - IndexBox
Is United Therapeutics Corporation (UTH) stock a top dividend aristocrat candidateJuly 2025 Sector Moves & Daily Volume Surge Signals - newser.com
Will United Therapeutics Corporation stock rally after Fed decisionsJuly 2025 Catalysts & Safe Investment Capital Preservation Plans - newser.com
United Therapeutics’ AI-Driven Study: A Potential Game-Changer for Pulmonary Hypertension Diagnosis - MSN
United Therapeutics Corp’s Earnings Call Highlights Growth and Innovation - MSN
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells 8,000 Shares - TradingView
United Therapeutics CorporationCommon Stock (Nasdaq:UTHR) Stock Quote - Markets Financial Content
P/E Ratio Insights for United Therapeutics - Benzinga
Is United Therapeutics Corp Gaining or Losing Market Support? - Sahm
United Therapeutics Corporation (UTHR) Stock Forecasts - Yahoo! Finance Canada
UBS Maintains United Therapeutics (UTHR) Buy Recommendation - Nasdaq
[Form 4] UNITED THERAPEUTICS Corp Insider Trading Activity - Stock Titan
Why United Therapeutics Corporation stock is trending among retail tradersMarket Growth Report & Daily Profit Maximizing Trade Tips - Fundação Cultural do Pará
United Therapeutics (NASDAQ:UTHR) CEO Sells $1,753,200.00 in Stock - MarketBeat
United Therapeutics CFO Sells Over $9 Million in Company Stock - TradingView
Will United Therapeutics Corporation stock benefit from upcoming earnings reportsQuarterly Investment Review & Advanced Technical Signal Analysis - newser.com
Access Investment Management LLC Makes New $2.14 Million Investment in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics (NASDAQ: UTHR) sets Nov 10 & 18 talks at UBS, Jefferies; webcasts - Stock Titan
United Therapeutics Corporation $UTHR Position Lessened by Bessemer Group Inc. - MarketBeat
Combining machine learning predictions for United Therapeutics CorporationMarket Performance Recap & Verified Technical Trade Signals - newser.com
United Therapeutics Corporation (UTHR) Stock forecasts - Yahoo Finance UK
United Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease - The Joplin Globe
United Therapeutics (Nasdaq: UTHR) starts EXPAND with first UKidney xenotransplant - Stock Titan
Can technical indicators confirm United Therapeutics Corporation’s reversalWeekly Stock Report & High Accuracy Swing Trade Signals - newser.com
Insider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells 4,000 Shares of Stock - MarketBeat
United Therapeutics Hits Day High with 9.63% Surge in Stock Price - Markets Mojo
MSN Money - MSN
United Therapeutics Corp. Hits New 52-Week High of $479.50 - Markets Mojo
United Therapeutics posts record revenue but misses Q3 earnings expectations - MSN
Focus Partners Advisor Solutions LLC Buys Shares of 1,440 United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics CEO Martine A. Rothblatt Sells 8,000 Shares - TradingView
Martine Rothblatt Sells 4,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat
3rd Circ. Preview: BMW, MiLB And Sandoz Top Nov. Lineup - Law360
United Therapeutics (NASDAQ:UTHR) Given New $423.00 Price Target at Wells Fargo & Company - MarketBeat
Assetmark Inc. Boosts Stock Holdings in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics Executives Sell Shares - TradingView
United Therapeutics Corp (UTHR) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance
Wells Fargo Maintains United Therapeutics (UTHR) Equal-Weight Recommendation - Nasdaq
United Therapeutics Grows Revenue, But Misses Earnings Forecast - Finimize
United Therapeutics (NASDAQ:UTHR) Reaches New 12-Month High After Better-Than-Expected Earnings - MarketBeat
United Therapeutics price target raised to $587 from $569 at RBC Capital - TipRanks
United Therapeutics price target raised to $447 from $435 at Morgan Stanley - TipRanks
United Therapeutics (UTHR) Earnings Transcript - AOL.com
United Therapeutics Corporation (NASDAQ:UTHR) Q3 2025 Earnings Call Transcript - Insider Monkey
United Therapeutics’ PHINDER Study: A Step Forward in Early Detection of Pulmonary Hypertension - MSN
Silver Spring-based United Therapeutics reports Q3 earnings - Maryland Daily Record
Published on: 2025-10-31 23:58:52 - newser.com
United Therapeutics: Q3 Earnings Snapshot - Stamford Advocate
United Therapeutics Reports Record Q3 2025 Results - TipRanks
Decoding United Therapeutics Corp (UTHR): A Strategic SWOT Insig - GuruFocus
United Therapeutics Q3 Earnings Beat Estimates, Revenues Miss Mark - MSN
United Therapeutics (NASDAQ:UTHR) COO Sells $9,393,750.00 in Stock - MarketBeat
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):